Fred B. Davenport Jr., President at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 25,000 shares at $66.20 ($1.7M) on 2006-02-15, disclosed to the SEC on 2006-02-15.
Open-market sale of $1.7M PPDI by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.03 | 1,000 | $66K | 4.0% |
| 2 | $66.05 | 5,000 | $330K | 20.0% |
| 3 | $66.08 | 1,000 | $66K | 4.0% |
| 4 | $66.08 | 2,000 | $132K | 8.0% |
| 5 | $66.10 | 7,500 | $496K | 30.0% |
| 6 | $66.12 | 1,500 |
| $99K |
| 6.0% |
| 7 | $66.15 | 2,000 | $132K | 8.0% |
| 8 | $66.17 | 2,500 | $165K | 10.0% |
| 9 | $66.20 | 2,500 | $166K | 10.0% |
| Total | $66.11 avg | 25,000 | $1.7M | 100% |
| Filing → |
| MEDP | SELL | 2025-04-28 | $1.0M | — | Filing → |
| MEDP | BUY | 2022-02-22 | $73K | — | Filing → |
| PPDI | SELL | 2006-12-19 | $2.2M | — | Filing → |